Resting CD8 T cells recognize β-galactosidase expressed in the immune-privileged retina and mediate autoimmune disease when activated

Immunology

Volumn 110, Issue 3, 2003, Pages 386-396

  Mcpherson, Scott W ^a   Yang, Jing ^a   Chan, Chi Chao ^b   Dou, Chunzhi ^a   Gregerson, Dale S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5(6) CARBOXYFLUORESCEIN DIACETATE N SUCCINIMIDYL ESTER; BETA GALACTOSIDASE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; GREEN FLUORESCENT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE UVEORETINITIS; AUTOIMMUNITY; BRAIN; CELL LABELING; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EYE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; RETINA; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE; UVEORETINITIS;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; BETA-GALACTOSIDASE; CD8-POSITIVE T-LYMPHOCYTES; CELL SURVIVAL; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RETINA; RETINITIS;

EID: 0242491044     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01750.x     Document Type: Article

References (45)

1. Jiang LQ, Jorquera M, Streilein JW. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 1993; 34:3347-54.
2. Wenkel H, Streilein JW. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Vis Sci 1998; 39:1823-34.
3. Gregerson DS, Dou C. Spontaneous induction of immunoregulation by an endogenous retinal protein. Invest Ophthalmol Vis Sci 2002; 43:2984-91.
4. Streilein JW. Immunologic privilege of the eye. Springer Semin Immunopathol 1999; 21:95-111 [Review].
5. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments]. Science 1995; 270:1189-92.
6. Forrester JV, McMenamin PG, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye - implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1994; 35:64-77.
7. Egwuagu CE, Charukamnoetkanok P, Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol 1997; 159:3109-12.
8. Dick AD, Broderick C, Forrester JV, Wright GJ. Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci 2001; 42:170-6.
9. Gregerson DS, Xiao J. Failure of memory (CD44 high) CD4 T cells to recognize their target antigen in retina. J Neuroimmunol 2001; 120:34-41.
10. Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic, and creates a target for autoimmune uveoretinitis. J Immunol 1999; 163:1073-80.
11. Zhang J, Wu GS, Ishimoto S, Pararajasegaram G, Rao NA. Expression of major histocompatibility complex molecules in rodent retina - immunohistochemical study. Invest Ophthalmol Vis Sci 1997; 38:1848-57.
12. Akaishi K, Ishiguro S, Durlu YK, Tamai M. Quantitative analysis of major histocompatibility complex class II-positive cells in posterior segment of Royal College of Surgeons rat eyes. Jpn J Ophthalmol 1998; 42:357-62.
13. Ishimoto S, Zhang J, Gullapalli VK, Pararajasegaram G, Rao NA. Antigen-presenting cells in experimental autoimmune uveoretinitis. Exp Eye Res 1998; 67:539-48.
14. Jiang HR, Lumsden L, Forrester JV. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci 1999; 40:3177-85.
15. Gregerson DS, Yang J. CD45-positive cells of the retina and their responsiveness to in vivo and in vitro treatment with IFN-γ or anti-CD40. Invest Ophthalmol Vis Sci 2003; 44:3083-93.
16. Dick AD, Ford AL, Forrester JV, Sedgwick JD. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol 1995; 79:834-40.
17. Johnson WB, Ruppe MD, Rockenstein EM, Price J, Sarthy VP, Verderber LC, Mucke L. Indicator expression directed by regulatory sequences of the glial fibrillary acidic protein (GFAP) gene: in vivo comparison of distinct GFAP-lacZ transgenes. Glia 1995; 13:174-84.
18. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993; 151:3971-80.
19. Dick LR, Aldrich C, Jameson SC et al. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to yield antigenic peptides. J Immunol 1994; 152:3884-94.
20. Bennink JR, Yewdell JW. Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function. Curr Top Microbiol Immunol 1990; 163:153-84.
21. Li X, Traganos F, Melamed MR, Darzynkiewicz Z. Single-step procedure for labeling DNA strand breaks with fluorescein-or BODIPY-conjugated deoxynucleotides: detection of apoptosis and bromodeoxyuridine incorporation. Cytometry 1995; 20:172-80.
22. Sgonc R, Wick G. Methods for the detection of apoptosis. Int Arch Allergy Immunol 1994; 105:327-32.
23. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994; 10:41-2.
24. McMenamin PG. Dendritic cells and macrophages in the uveal tract of the normal mouse eye. Br J Ophthalmol 1999; 83:598-604.
25. Steptoe RJ, Holt PG, McMenamin PG. Major histocompatibility complex (MHC) class II-positive dendritic cells in the rat iris. In situ development from MHC class II-negative precursors. Invest Ophthalmol Vis Sci 1997; 38:2639-48.
26. + T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat Immunol 2001; 2:415-22.
27. Tuma RA, Pamer EG. Homeostasis of naive, effector and memory CD8 T cells. Curr Opin Immunol 2002; 14:348-53.
28. van Stipdonk MJ, Lemmens EE, Schoenberger SP. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat Immunol 2001; 2:423-9.
29. Balendiran GK, Solheim JC, Young AC, Hansen TH, Nathenson SG, Sacchettini JC. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proc Natl Acad Sci USA 1997; 94:6880-5.
30. Schmidt CS, Mescher MF. Peptide antigen priming of naive, but not memory, CD8 T cells requires a third signal that can be provided by IL-12. J Immunol 2002; 168:5521-9.
31. Rogers PR, Dubey C, Swain SL. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol 2000; 164:2338-46.
32. Romanic AM, Graesser D, Baron JL, Visintin I, Janeway CA Jr, Madri JA. T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial cell migration. Lab Invest 1997; 76:11-23.
33. Prendergast RA, Iliff CE, Coskuncan NMm, Caspi RR, Sartani G, Tarrant TK, Lutty GA, McLeod DS. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Vis Sci 1998; 39:754-62.
34. Farr AG, Rudensky A. Medullary thymic epithelium: a mosaic of epithelial 'self'. J Exp Med 1998; 188:1-4.
35. Ng TF, Streilein JW. Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001; 42:3301-10.
36. McPherson SW, Roberts JP, Gregerson DS. Systemic expression of rat soluble retinal antigen induces resistance to experimental autoimmune uveoretinitis. J Immunol 1999; 163:4269-76.
37. Xu H, Wawrousek EF, Redmond TM, Nickerson JM, Wiggert B, Chan CC, Caspi RR. Transgenic expression of an immunologically privileged retinal antigen extraocularly enhances self tolerance and abrogates susceptibility to autoimmune uveitis. Eur J Immunol 2000; 30:272-8.
38. Gregerson DS, Obritsch WF, Fling SP, Cameron JD. S-antigen-specific rat T cell lines recognize peptide fragments of S-antigen and mediate experimental autoimmune uveoretinitis and pinealitis. J Immunol 1986; 136:2875-82.
39. Hickey W, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239:290-2.
40. Gullapalli VK, Zhang J, Pararajasegaram G, Rao NA. Hematopoietically derived retinal perivascular microglia initiate uveoretinitis in experimental autoimmune uveitis. Graefes Arch Clin Exp Ophthalmol 2000; 238:319-25.
41. Kimura A, Singh D, Wawrousek EF, Kikuchi M, Nakamura M. Shinohara T. Both PCE-1/RX and OTX/CRX interactions are necessary for photoreceptor-specific gene expression. J Biol Chem 2000; 275:1152-60.
42. Kikuchi T, Wawrousek E, Lee T, Di Camillo S, Kusuzaki K, Shinohara T. Position or number of photoreceptor conserved element (PCE1) in arrestin promoter may be altered in molecular evolution. Invest Ophthalmol Vis Sci 1995; 36:5772 [Abstr.].
43. Kikuchi T, Raju K, Breitman ML, Shinohara T. The proximal promoter of the mouse arrestin gene directs gene expression in photoreceptor cells and contains an evolutionarily conserved retinal factor-binding site. Mol Cell Biol 1993; 13:4400-8.
44. Mani SS, Besharse JC, Knox BE. Immediate upstream sequence of arrestin directs rod-specific expression in Xenopus. J Biol Chem 1999; 274:15590-7.
45. Sunayashiki-Kusuzaki K, Kikuchi T, Wawrousek EF, Shinohara T. Arrestin and phosducin are expressed in a small number of brain cells. Mol Brain Res 1997; 52:112-20.